UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1

PloS one, 2013-08, Vol.8 (8), p.e71449-e71449

2013

Link zum Volltext

Verfügbarkeit prüfen

Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors

BMC cancer, 2013-08, Vol.13 (1), p.382-382, Article 382

2013

Link zum Volltext

Verfügbarkeit prüfen

Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial

The lancet oncology, 2017-05, Vol.18 (5), p.672-681

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma

Marine drugs, 2009-03, Vol.7 (1), p.57-70

2009

Link zum Volltext

Verfügbarkeit prüfen

Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients

Cell reports (Cambridge), 2016-05, Vol.15 (6), p.1134-1143

2016

Link zum Volltext

Verfügbarkeit prüfen

Transcription Factors Sp1 and p73 Control the Expression of the Proapoptotic Protein NOXA in the Response of Testicular Embryonal Carcinoma Cells to Cisplatin

The Journal of biological chemistry, 2012-08, Vol.287 (32), p.26495-26505

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeted Therapies in Sarcomas: Challenging the Challenge

Sarcoma, 2012, Vol.2012, p.626094-13

2012

Link zum Volltext

Verfügbarkeit prüfen

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

Journal of clinical oncology, 2011-12, Vol.29 (35), p.4677-4681

2011

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma

European urology open science (Online), 2023-12, Vol.58, p.28-36

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8717-8723

2005

Link zum Volltext

Verfügbarkeit prüfen

PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate

Cancer management and research, 2020-01, Vol.12, p.10251-10260

2020

Link zum Volltext

Verfügbarkeit prüfen

Sirolimus plus gemcitabine: a new therapeutic combination for resistant sarcomas?

Expert review of anticancer therapy, 2015-03, Vol.15 (3), p.257-259

2015

Link zum Volltext

Verfügbarkeit prüfen

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma

Journal of clinical oncology, 2016-11, Vol.34 (32), p.3898-3905

2016

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2009-08, Vol.27 (22), p.3584-3590

2009

Link zum Volltext

Verfügbarkeit prüfen

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

The Lancet (British edition), 2017-11, Vol.390 (10109), p.2266-2277

2017

Link zum Volltext

Verfügbarkeit prüfen

Nilotinib, imatinib, and GIST therapy

The lancet oncology, 2015-05, Vol.16 (5), p.483-484

del Muro, Xavier Garcia

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas

OncoTargets and therapy, 2019-11, Vol.12, p.9265-9275

2019

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic loss of the PIWI/piRNA machinery in human testicular tumorigenesis

Epigenetics, 2014-01, Vol.9 (1), p.113-118

2014

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

The lancet oncology, 2009-11, Vol.10 (11), p.1045-1052

2009

Link zum Volltext

Verfügbarkeit prüfen

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma

Cancer chemotherapy and pharmacology, 2014-06, Vol.73 (6), p.1095-1107

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(224)

Publikationsform

Sprache

Englisch
(225)
Japanisch
(23)
Spanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(123)
Life Sciences & Biomedicine
(109)
Humans
(92)
Oncology
(89)
Male
(55)
Tumors
(49)
Adult
(38)
Female
(38)
Middle Aged
(36)
Aged
(30)
Antineoplastic Agents - Therapeutic Use
(27)
Prognosis
(27)
Biological And Medical Sciences
(22)
Chemotherapy
(22)
Medical Sciences
(22)
Neoplasm Staging
(20)
Metastasis
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Medicine
(16)
Disease-Free Survival
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study

Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors

Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial

Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma

Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients

Transcription Factors Sp1 and p73 Control the Expression of the Proapoptotic Protein NOXA in the Response of Testicular Embryonal Carcinoma Cells to Cisplatin

Targeted Therapies in Sarcomas: Challenging the Challenge

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma

Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study

PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate

Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)

Sirolimus plus gemcitabine: a new therapeutic combination for resistant sarcomas?

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Nilotinib, imatinib, and GIST therapy

Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas

Epigenetic loss of the PIWI/piRNA machinery in human testicular tumorigenesis

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma

Suchergebnisse filtern